Taysha Gene Therapies, Inc. (TSHA)

Typically moves ±15.36% on earnings

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-11-06 ESTIMATED

Taysha Gene Therapies, Inc. (TSHA) has reported earnings 23 times since Mar 03, 2021. The stock moves an average of ±15.36% the day after reporting, closing higher 56.5% of the time. Its largest post-earnings gain was +188.23% (Aug 14, 2023) and its largest decline was -19.06% (Aug 11, 2022). The next earnings report is predicted for 2026-11-06 (estimated).

Earnings reactions

How TSHA moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±15.36%

Positive %

56.5%

Negative %

43.5%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Aug 11, 2026	☽ POST	-3.83%	open_in_new
May 06, 2026	☀ PRE	+0.58%	open_in_new
Mar 19, 2026	☀ PRE	+2.47%	open_in_new
Nov 04, 2025	☀ PRE	-4.26%	open_in_new
Aug 12, 2025	☀ PRE	+5.43%	open_in_new
May 15, 2025	☀ PRE	+8.02%	open_in_new
Feb 26, 2025	☀ PRE	-4.71%	open_in_new
Nov 13, 2024	☽ POST	+2.71%	open_in_new
Aug 12, 2024	☀ PRE	-2.39%	open_in_new
Jun 26, 2024	☀ PRE	-17.24%	open_in_new
Mar 19, 2024	☽ POST	+31.56%	open_in_new
Nov 14, 2023	☽ POST	+26.32%	open_in_new
Aug 14, 2023	☀ PRE	+188.23%	open_in_new
May 15, 2023	☽ POST	-0.14%	open_in_new
Mar 28, 2023	☽ POST	-0.31%	open_in_new
Nov 08, 2022	☀ PRE	+10%	open_in_new
Aug 11, 2022	☀ PRE	-19.06%	open_in_new
May 16, 2022	☀ PRE	-3.49%	open_in_new
Mar 31, 2022	☀ PRE	+6.02%	open_in_new
Nov 10, 2021	☀ PRE	+5.14%	open_in_new
Aug 16, 2021	☀ PRE	-8.98%	open_in_new
May 11, 2021	☀ PRE	+2.34%	open_in_new
Mar 03, 2021	☀ PRE	+0%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±15.36%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 26 →

Funds holding

$546522555

Total value held

Buying

20 added · 5 reduced

Goldman Sachs Group Inc

$154676334 +1.54%

Blackrock, Inc.

$140912023 +12.67%

Morgan Stanley

$112279731 -8.23%

State Street Corp

$77783275 +1.90%

Northern Trust Corp

$15160491 +22.70%

SEC Filing Types

description SCHEDULE 13G/A

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
SCHEDULE 13G/A	20260814	open_in_new SEC.gov
SCHEDULE 13G/A	20260813	open_in_new SEC.gov
10-Q	20260811	open_in_new SEC.gov
8-K	20260811	open_in_new SEC.gov
144	20260710	open_in_new SEC.gov
4	20260710	open_in_new SEC.gov
424B5	20260625	open_in_new SEC.gov
8-K	20260625	open_in_new SEC.gov
424B5	20260624	open_in_new SEC.gov
8-K	20260622	open_in_new SEC.gov

Frequently asked about TSHA earnings

When does Taysha Gene Therapies, Inc. report earnings next? expand_more

Taysha Gene Therapies, Inc. (TSHA)'s next earnings date is estimated for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does TSHA stock move after earnings? expand_more

Over 23 reports, TSHA has moved an average of ±15.36% the session after earnings, closing higher 56.5% of the time.

What was TSHA's biggest post-earnings move? expand_more

TSHA's largest post-earnings gain on record was +188.23% on Aug 14, 2023, and its largest decline was -19.06% on Aug 11, 2022.

Where can I find Taysha Gene Therapies, Inc.'s SEC filings? expand_more

All of Taysha Gene Therapies, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.